Roles of membrane-bound lectins in the regulation of immune cells.
Roles of membrane-bound lectins in the regulation of immune cells.
批准号:
15390158
负责人:
TSUBATA Takeshi
金额:
$9.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CD22 is a member of the siglec family and specifically recognizes a2,6 sialic acid, whereas CD72 contains a C-type lectin domain. These membrane-bound lectin molecules contain the immunoreceptor tyrosine-based inhibition motifs (ITIMs) in the cytoplasmic region. Upon phosphorylation, these ITIMs recruit and activate the SH2 domain containing tyrosine phosphatase 1 (SHP1), thereby down-regulate BCR signaling. We demonstrated that CD22-mediated signal regulation depends on the immunoglobulin isotypes of BCR. Indeed, CD22 negatively regulates signaling through IgM-BCR, IgD-BCR and IgA-BCR, but not signaling through IgG-BCR or IgE-BCR. In the absence of CD22-mediated signaling inhibition, IgG-BCR and IgE-BCR transmit augmented signaling, which may be involved in rapid antibody production in memory responses. The cytoplasmic regions of membrane form of IgG and IgE are involved in abrogation of CD22-mediated signal inhibition. In contrast, CD72 regulates BCR signaling regardless of Ig isotypes. SHP-1 contains two SH2 domains, and at least two out of tree ITIMs in CD22 are suggested to be essential for recruitment of SHP-1. We demonstrated that one ITIM is sufficient for recruitment of SHP-1 to CD22 and CD22-mediated signal regulation. Moreover, tyrosine at the position 783 locating in an ITIM appears to regulate phosporylation of other tyrosines in the cytoplamic region of CD22. These findings are crucial for elucidation of the function of membrane-bound lectins, and development of new strategies for controlling B cell function.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hokazono, Y., Adachi, T., Wabl, M., Tada, N., Amagasa, T., Tsubata T.: "Inhibitory co-receptors activated by antigens but not by anti immunoglobulin heavy chain antibodies install requirement of co-stimulation through CD40 for survival and proliferation o
Hokazono,Y.,Adachi,T.,Wabl,M.,Tada,N.,Amagasa,T.,Tsubata T.:“由抗原激活的抑制性共受体,但不由抗免疫球蛋白重链抗体激活,需要共-
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Involvement of cell cycle progression in survaival signaling through CD40 inB lymphocyte line Wehi-231.
通过 B 淋巴细胞系 Wehi-231 中的 CD40 参与细胞周期进程的生存信号传导。
DOI:
--
发表时间:
2003
期刊:
Cell. Death. Differ 11
影响因子:
--
作者:
[Hirai H, Adachi T, Tsubata T.]
通讯作者:
Tsubata T.
Inhibitory co-receptors activated by antigens but not by anti immunoglobulin heavy chain antibodies install requirement of co-stimulation through CD40 for survival and proliferation of B cells.
由抗原激活但不由抗免疫球蛋白重链抗体激活的抑制性共受体需要通过 CD40 进行共刺激才能使 B 细胞存活和增殖。
DOI:
--
发表时间:
2003
期刊:
J. Immunol. 171
影响因子:
--
作者:
[Hokazono, Y., Adachi, T., Wabl, M., Tada, N., Amagasa, T., Tsubata' T.]
通讯作者:
Tsubata' T.
Suzuki, A, Kaisho, T., Ohishi, M., Tsukio-Yamaguchi, M., Tsubata T., Koni, P.A., Sasaki, T., Mak, T.W., Nakano, T。: "Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination."J.Exp.Med.. 197. 657-667 (2003)
铃木,A,Kaisho,T.,Ohishi,M.,Tsukio-Yamaguchi,M.,Tsubata T.,Koni,P.A.,Sasaki,T.,Mak,T.W.,Nakano,T.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Involvement of cell cycle progression in survival signaling through CD40 in B lymphocyte line WEHI-231
B 淋巴细胞系 WEHI-231 中通过 CD40 参与细胞周期进程的生存信号传导
DOI:
--
发表时间:
2004
期刊:
Cell Death Differ. 11
影响因子:
--
作者:
[Hirai, H., Adachi, T., Tsubata, T.]
通讯作者:
T.
Studies on Siglecs expressed on B lymphocytes and their glycan ligands
-
批准号:26293062
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.32万
-
财政年份:2014
-
负责人:TSUBATA Takeshi
-
依托单位:
Carbohydrate recognition of B lymphocyte lectins and their function
-
批准号:23390063
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.32万
-
财政年份:2011
-
负责人:TSUBATA Takeshi
-
依托单位:
Immunogenetic analysis of the resistance to infectious diseases
-
批准号:18406019
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.89万
-
财政年份:2006
-
负责人:TSUBATA Takeshi
-
依托单位:
Regulation of cell death by cell cycling
-
批准号:13043013
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$67.97万
-
财政年份:2001
-
负责人:TSUBATA Takeshi
-
依托单位:
Study on transcriptional regulation in CD40 signaling.
-
批准号:12670295
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:TSUBATA Takeshi
-
依托单位:
Regulatory mechanisms for self-reactive B cells with somatic mutations in the immunoglobulin genes
-
批准号:09470092
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:1997
-
负责人:TSUBATA Takeshi
-
依托单位:
Study of CDK inhibitors in B cell immune response
-
批准号:09044292
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.65万
-
财政年份:1997
-
负责人:TSUBATA Takeshi
-
依托单位:
Establishment of a spontaneous single gene model for Sjogren's syndrome
-
批准号:07557032
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$1.28万
-
财政年份:1995
-
负责人:TSUBATA Takeshi
-
依托单位:
Control mechanisms for B cell apoptosis and differentiation
-
批准号:06044130
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$9.34万
-
财政年份:1994
-
负责人:TSUBATA Takeshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
外周血中B淋巴细胞BCR CDR3分子特征监测在乙型肝炎患者疗效预测中的应用研究
-
批准号:2026JJ81604
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王小妹
-
依托单位:
EB病毒蛋白BZLF1上调CD40/CD40L-
KU80/RAG信号通路促进BCR二次重排在机
体丧失自身免疫耐受的机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:侯显良
-
依托单位:
巴弗洛霉素A1通过抑制Lamp-1介导的BCR信号通路提高淋巴瘤化疗
敏感性的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:黄文秋
-
依托单位:
TED患者BCR组库的偏倚及TSHR特异性B细胞来源的鉴定
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:朱燕
-
依托单位:
解毒化瘀益髓法治疗BCR-ABL阴性骨髓增殖性肿瘤的临床研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:5.0万元
-
批准年份:2024
-
负责人:邵雅聪
-
依托单位:
大白菜抗根肿病主效QTL Bcr1的功能鉴定
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
含S-烯丙基巯基半胱氨酸结构的新型Bcr-Abl抑制剂的设计、合成与生物活性研究
-
批准号:2023JJ30525
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:彭俊梅
-
依托单位:
新型Skp2抑制剂阻抑Skp2/Bcr-Abl信号通道诱导Ph+急性淋巴细胞白血病细胞衰老及其机制研究
-
批准号:82300196
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘金宜
-
依托单位:
谷胱甘肽转移酶GSTP1靶向BCR-ABL在慢粒中的作用与分子机制
-
批准号:82300188
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:马赛
-
依托单位:
AID介导抗体重链非编码区重组调控质膜BCR密度并影响记忆B细胞命运决定的研究
-
批准号:32370948
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:童佩
-
依托单位: